News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|March 1, 1996

Supplements and Featured Publications

Current Strategies in the Treatment of Cardiovascular Diseases: The Role of Beta-Blocker Therapy
Volume 2
Issue 5 Suppl

Sympathetic Modulation in Congestive Heart Failure: Where Do Beta-Blockers Stand?

Author(s)Finn Waagstein, MD, PhD

Download PDF: Sympathetic Modulation in Congestive Heart Failure: Where Do Beta-Blockers Stand?

Articles in this issue

almost 30 years ago

Article

almost 30 years ago

Article

Utilization of Beta-Blockers: A First-Line Therapy in Hypertension

almost 30 years ago

Article

Dispelling the Myths: Treatment of Patients with Ischemic Heart Disease and Left Ventricular Dysfunction

almost 30 years ago

Article

Suggested Reading

almost 30 years ago

Article

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC original research clinical

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

AJMC original research managerial

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

ByPamela S. Roberts, PhD, OTR/L,Chih-Ying Li, PhD, OTR/L,Debra S. Ouellette, MS, OTR/L,Nabeel Qureshi, MPH,Erica Spivack, MHA,Mary Nasmyth, MD,Nancy L. Sicotte, MD,Zaldy S. Tan, MD

December 22nd 2025

AJMC original research managerial

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

ByJoshua R. Vest, PhD, MPH,Christopher A. Harle, PhD,Justin Blackburn, PhD

December 19th 2025

AJMC original research policy

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Katarzyna Rodchenko, MA, MPH,Lauren Isenman, MPH,Xue Han, PhD,Deborah Freedman, MBA,Rashmi Patel, MD, PhD

December 17th 2025

AJMC commentary

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

ByGury K. Doshi, MD,Lucio Gordan, MD,Kirollos Hanna, PharmD,Scott Freeswick, PharmD,Natalie Dickson, MD,Desi Kotis, PharmD,Osama Abdelghany, PharmD, MHA,Ken Komorny, PharmD,Neal Dave, PharmD,Michael Reff, RPh, MBA

December 16th 2025

Trending on AJMC

ICYMI: Highlights From ASH 2025

Top 5 Most-Read Reimbursement Content of 2025

Top 5 Most-Read Dermatology Content of 2025

Top 5 Most-Read HIV Articles of 2025

Evidence Suggests Bidirectional Risk Between Ovarian, Colorectal Cancers

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.